Focus on Haemostasis

Stago accelerates its growth with ARCHIMED and La Caisse

Communication of April 29, 2026

For nearly eighty years, Stago has been developing solutions grounded in rigorous scientific standards, driven by a constant ambition: to support healthcare professionals and contribute to improved patient care.

As a leading global player in hemostasis, the company has built its identity on a culture of excellence, recognized expertise, and a long-term vision.

Today, Stago is entering a new phase in its history.

Royal Sussex County Hospital Becomes First UK Site to Install Stago’s sthemO 301 Haemostasis System

Royal Sussex County Hospital Becomes First UK Site to Install Stago’s sthemO 301 Haemostasis System

Brighton, UK – March 2026 — Stago UK is proud to announce the first UK installation of the sthemO 301 haemostasis analyser at the Royal Sussex County Hospital, part of University Hospitals Sussex NHS Foundation Trust. This milestone marks the beginning of a new chapter in haemostasis diagnostics for the Trust and for Stago’s next-generation technology in the UK.

Voice of the Lab: Expert Rules in Action at Hampshire Hospitals

We’re proud to share the latest edition of Voice of the Lab, featuring Nina Harrison, Special Coagulation Operations Manager at Basingstoke and North Hampshire Hospital.
Nina Harrison’s lab has implemented a wide range of Expert Rules using the Stago Data Manager, improving workflows and outcomes. From automating factor assays and lupus anticoagulant testing to reflex Von Willebrand factor analysis, the impact has been clear:

PiP September 2025 sthemO 201 evaluation Cambridge

Stago sthemO 201 meets Specialist haemostasis labs unique challenges

In a recent evaluation at the Addenbrooke's Hospital Specialist Haemostasis Unit lab in Cambridge, Stago’s bench-top coagulation analyser, sthemO 201, demonstrated the potential to “help laboratories enhance precision, improve efficiency, and support safer, more reliable clinical decision-making”.

Stago Educational Talk "The What-When-How-Why (and Now what) of HIT testing"

In this Stago Educational Talk, Peter Baker, Clinical Scientist at Oxford Haemophilia and Thrombosis Centre, breaks down all the essentials of Heparin-Induced Thrombocytopenia (HIT) laboratory testing, following the British Society of Haematology guideline: "Diagnosis and management of heparin-induced thrombocytopenia (Third edition). It now includes functional assays in the diagnosis of (HIT), when to use direct-acting oral anti-coagulants, and more.